Allurion Technologies, Inc. ALUR 深 沪
等待开盘 02-07 09:30:00 美东时间
1.12
+0.050
+4.67%
华盛通- 最 高1.14
- 今 开1.06
- 成交量 3.56万股
- 最 低 1.04
- 昨 收 1.07
- 总市值 303.66万
- 52周最高 5.78
- 市盈率 静 --
- 换手率 1.31%
- 52周最低 0.95
- 委 比 77.78%
- 总股本 271.13万
- 历史最高 225.00
- 量 比 0.41
- 振 幅 9.35%
- 历史最低 0.95
- 每 手 1
- 风险率 0.89%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Allurion Technologies shares are trading higher after the company issued Q4 preliminary revenue guidance above estimates.
Allurion Technologies shares are trading higher after the company issued Q4 pre...
01-13 02:14
Allurion Technologies Reports Initial Results On Combination Of Allurion Program With Low-Dose Tirzepatide Therapy To Optimize Muscle Mass And GLP-1 Adherence
Average Total Weight Loss of 23% With 14% Increase in Lean Body Mass After 12 MonthsAll patients remained adherent to tirzepatide for the duration of the studyAllurion Technologies, Inc. ("Allurion" or the "Company")
2025-11-25 22:28
美股大行评级 | 最高352美元！14家机构连夜上调英伟达目标价；劳氏、塔吉特、Wix.com等遭多家机构下调目标价
今日重点评级关注：Ascendiant Capital：维持Aclarion"买入"评级，目标价从22美元升至23美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从24美元升至26美元
2025-11-21 15:50
Allurion Technologies Announces Strategic Distribution Partnership With ProSurg Medical To Establish New Standard Of Care Focused On Metabolically Healthy Weight Loss
Allurion Technologies, Inc. (NYSE:ALUR), a pioneer in metabolically healthy weight loss, today announced a strategic distribution partnership with ProSurg Medical, a leading Brazilian medical device company specializing
2025-11-18 22:09
Allurion Technologies Q3 Adj. EPS $(1.18) Misses $(1.17) Estimate, Sales $2.658M Beat $2.350M Estimate
Allurion Technologies (NYSE:ALUR) reported quarterly losses of $(1.18) per share which missed the analyst consensus estimate of $(1.17) by 0.6 percent. This is a 66.29 percent increase over losses of $(3.50) per share
2025-11-12 21:03
Earnings Scheduled For November 12, 2025
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
2025-11-12 19:11
Allurion Technologies Passes Critical Milestones In U.S. FDA's Pre-Market Approval Process For Allurion Smart Capsule; Company To Exchange All Outstanding Debt, Obligations For Shares Of Newly Created Series B Convertible Preferred Stock
Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion" or the "Company"), a pioneer in metabolically healthy weight loss, today announced it has passed critical milestones in the U.S. Food and Drug Administration (the
2025-11-11 21:51
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
Gainers Mixed Martial Arts Group (AMEX:MMA) shares moved upwards by 26.4% to $...
2025-08-21 01:06
Allurion Technologies Shifts Strategy Amid Q2 Earnings
Allurion Technologies, Inc. ( ($ALUR) ) has released its Q2 earnings. Here is a...
2025-08-14 12:32
